What's new

CHMP-CAT - D80-210 Overview to final EPAR - Rev 06.25 Revamp

CHMP-CAT - D80-210 Overview to final EPAR - Rev 06.25 Revamp

Jun 10, 2025 - 11:05
 0
CHMP-CAT - D80-210 Overview to final EPAR - Rev 06.25 Revamp
Read More

Tags:

Previous Article

Quality control of medicinal product data submitted as per the legal requirement...

Next Article

Day 80 assessment report - Non-clinical template with guidance - Rev 06.25 Revamp

Related Posts

Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 6, 2025  0